Egg-allergic patients gain greater access to H1N1 vaccine after completion of clinical trial.
Identifieur interne : 000672 ( Main/Exploration ); précédent : 000671; suivant : 000673Egg-allergic patients gain greater access to H1N1 vaccine after completion of clinical trial.
Auteurs : Laura EggertsonSource :
- CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne [ 1488-2329 ] ; 2010.
Descripteurs français
- KwdFr :
- Accessibilité des services de santé (MeSH), Anaphylaxie (prévention et contrôle), Anaphylaxie (épidémiologie), Calendrier d'administration des médicaments (MeSH), Canada (épidémiologie), Essais cliniques comme sujet (MeSH), Grippe humaine (immunologie), Guides de bonnes pratiques cliniques comme sujet (MeSH), Humains (MeSH), Hypersensibilité à l'oeuf (épidémiologie), Sous-type H1N1 du virus de la grippe A (immunologie), Vaccins antigrippaux (administration et posologie).
- MESH :
- administration et posologie : Vaccins antigrippaux.
- immunologie : Grippe humaine, Sous-type H1N1 du virus de la grippe A.
- prévention et contrôle : Anaphylaxie.
- épidémiologie : Anaphylaxie, Canada, Hypersensibilité à l'oeuf.
- Accessibilité des services de santé, Calendrier d'administration des médicaments, Essais cliniques comme sujet, Guides de bonnes pratiques cliniques comme sujet, Humains.
- Wicri :
- geographic : Canada.
English descriptors
- KwdEn :
- Anaphylaxis (epidemiology), Anaphylaxis (prevention & control), Canada (epidemiology), Clinical Trials as Topic (MeSH), Drug Administration Schedule (MeSH), Egg Hypersensitivity (epidemiology), Health Services Accessibility (MeSH), Humans (MeSH), Influenza A Virus, H1N1 Subtype (immunology), Influenza Vaccines (administration & dosage), Influenza, Human (immunology), Practice Guidelines as Topic (MeSH).
- MESH :
- chemical , administration & dosage : Influenza Vaccines.
- geographic , epidemiology : Canada.
- epidemiology : Anaphylaxis, Egg Hypersensitivity.
- immunology : Influenza A Virus, H1N1 Subtype, Influenza, Human.
- prevention & control : Anaphylaxis.
- Clinical Trials as Topic, Drug Administration Schedule, Health Services Accessibility, Humans, Practice Guidelines as Topic.
DOI: 10.1503/cmaj.109-3123
PubMed: 19969568
PubMed Central: PMC2817345
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Egg-allergic patients gain greater access to H1N1 vaccine after completion of clinical trial.</title>
<author><name sortKey="Eggertson, Laura" sort="Eggertson, Laura" uniqKey="Eggertson L" first="Laura" last="Eggertson">Laura Eggertson</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2010">2010</date>
<idno type="RBID">pubmed:19969568</idno>
<idno type="pmid">19969568</idno>
<idno type="doi">10.1503/cmaj.109-3123</idno>
<idno type="pmc">PMC2817345</idno>
<idno type="wicri:Area/Main/Corpus">000712</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000712</idno>
<idno type="wicri:Area/Main/Curation">000712</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000712</idno>
<idno type="wicri:Area/Main/Exploration">000712</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Egg-allergic patients gain greater access to H1N1 vaccine after completion of clinical trial.</title>
<author><name sortKey="Eggertson, Laura" sort="Eggertson, Laura" uniqKey="Eggertson L" first="Laura" last="Eggertson">Laura Eggertson</name>
</author>
</analytic>
<series><title level="j">CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne</title>
<idno type="eISSN">1488-2329</idno>
<imprint><date when="2010" type="published">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anaphylaxis (epidemiology)</term>
<term>Anaphylaxis (prevention & control)</term>
<term>Canada (epidemiology)</term>
<term>Clinical Trials as Topic (MeSH)</term>
<term>Drug Administration Schedule (MeSH)</term>
<term>Egg Hypersensitivity (epidemiology)</term>
<term>Health Services Accessibility (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Influenza A Virus, H1N1 Subtype (immunology)</term>
<term>Influenza Vaccines (administration & dosage)</term>
<term>Influenza, Human (immunology)</term>
<term>Practice Guidelines as Topic (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Accessibilité des services de santé (MeSH)</term>
<term>Anaphylaxie (prévention et contrôle)</term>
<term>Anaphylaxie (épidémiologie)</term>
<term>Calendrier d'administration des médicaments (MeSH)</term>
<term>Canada (épidémiologie)</term>
<term>Essais cliniques comme sujet (MeSH)</term>
<term>Grippe humaine (immunologie)</term>
<term>Guides de bonnes pratiques cliniques comme sujet (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Hypersensibilité à l'oeuf (épidémiologie)</term>
<term>Sous-type H1N1 du virus de la grippe A (immunologie)</term>
<term>Vaccins antigrippaux (administration et posologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Canada</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Anaphylaxis</term>
<term>Egg Hypersensitivity</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Grippe humaine</term>
<term>Sous-type H1N1 du virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term>
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Anaphylaxis</term>
</keywords>
<keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Anaphylaxie</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Anaphylaxie</term>
<term>Canada</term>
<term>Hypersensibilité à l'oeuf</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Clinical Trials as Topic</term>
<term>Drug Administration Schedule</term>
<term>Health Services Accessibility</term>
<term>Humans</term>
<term>Practice Guidelines as Topic</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Accessibilité des services de santé</term>
<term>Calendrier d'administration des médicaments</term>
<term>Essais cliniques comme sujet</term>
<term>Guides de bonnes pratiques cliniques comme sujet</term>
<term>Humains</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Canada</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19969568</PMID>
<DateCompleted><Year>2010</Year>
<Month>03</Month>
<Day>23</Day>
</DateCompleted>
<DateRevised><Year>2010</Year>
<Month>02</Month>
<Day>09</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1488-2329</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>182</Volume>
<Issue>2</Issue>
<PubDate><Year>2010</Year>
<Month>Feb</Month>
<Day>09</Day>
</PubDate>
</JournalIssue>
<Title>CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne</Title>
<ISOAbbreviation>CMAJ</ISOAbbreviation>
</Journal>
<ArticleTitle>Egg-allergic patients gain greater access to H1N1 vaccine after completion of clinical trial.</ArticleTitle>
<Pagination><MedlinePgn>E99-100</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1503/cmaj.109-3123</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Eggertson</LastName>
<ForeName>Laura</ForeName>
<Initials>L</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016433">News</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2009</Year>
<Month>12</Month>
<Day>07</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Canada</Country>
<MedlineTA>CMAJ</MedlineTA>
<NlmUniqueID>9711805</NlmUniqueID>
<ISSNLinking>0820-3946</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000707" MajorTopicYN="N">Anaphylaxis</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002986" MajorTopicYN="Y">Clinical Trials as Topic</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D021181" MajorTopicYN="N">Egg Hypersensitivity</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006297" MajorTopicYN="Y">Health Services Accessibility</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017410" MajorTopicYN="N">Practice Guidelines as Topic</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year>
<Month>12</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2009</Year>
<Month>12</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2010</Year>
<Month>3</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">19969568</ArticleId>
<ArticleId IdType="pii">cmaj.109-3123</ArticleId>
<ArticleId IdType="doi">10.1503/cmaj.109-3123</ArticleId>
<ArticleId IdType="pmc">PMC2817345</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list></list>
<tree><noCountry><name sortKey="Eggertson, Laura" sort="Eggertson, Laura" uniqKey="Eggertson L" first="Laura" last="Eggertson">Laura Eggertson</name>
</noCountry>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeCanadaV4/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000672 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000672 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= GrippeCanadaV4 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:19969568 |texte= Egg-allergic patients gain greater access to H1N1 vaccine after completion of clinical trial. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:19969568" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a GrippeCanadaV4
This area was generated with Dilib version V0.6.35. |